Gilead’s Remdesivir Will Be Distributed By State Health Departments
NIH clinical trial tests Remdesivir plus anti-inflammatory drug Baricitinib for COVID-19
How This Crisis Differs from the 2008–2009 Financial Crisis
NIH kicks off combo study on the impact of Eli Lilly’s Olumiant on Covid-19 cases — using a dose rejected as too dangerous for RA
A New Divergence?
RBC: 2 Strong Value Stocks to Buy Now
Week Ahead – Reopening economies appear to be the only trade in town
What would it take to deploy COVID-19 vaccines through sustainable cold chains?
Look for housing to rescue the economy, Nothaft says
Can I Still Live on My Retirement in the Coronavirus Era?
Markets, the economy and the virus
Managing Financial Hardship during the Unprecedented Pandemic
JPMorgan: 3 Stocks That Could Surge Over 30%
Pandemic Causes Loss of 20,500,000 Jobs, Unemployment at 14.7 Percent
Are buoyant stock markets out of step with economic reality?
3 Big Dividend Stocks Yielding at Least 10%; Maxim Says ‘Buy’
When Will The US Coronavirus Recession Peak?
Illinois Tool Works (ITW) Earnings Report Shows Revenue and EPS Decline for Q1 2020
Daily market commentary: European equities edge higher
Asia Finding Love On The Rebound
Market Too Far Ahead of Economy?
Price of Silver Boom After COVID-19 Collapse
SolarEdge Shares Tank 13% on Weaker Revenue Outlook
Arena Investors March 2020 Commentary
Jobless Numbers Soar Again
Cash-Strapped Norwegian Cruise Line Spikes on $2.2 Billion Lifeline
Tactical Asset Allocation Views – May 2020
Patterns—and some implications—of Covid-19 financial sector policy interventions
State-Owned Enterprises in the Time of COVID-19
Fitch Cuts GM’s Rating to Just Above Junk Due to Prolonged Virus Recovery